REFERENCES
- Murphy R, Turnbull DM, Walker M, et al. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med. 2008;25:383–399.
- Marmor MF, Fulton AB, Holder GE, et al. Standard for clinical electroretinography (2008 update). Doc Ophthalmol 2009;118:69–77.
- Andrews RM, Kubacka I, Chinnery PF, et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999;23:147.
- Whittaker RG, Blackwood JK, Alston CL, et al. Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. Neurology 2009;72:568–569.
- Engel AG. The muscle biopsy. In: Engel A, Franzini-Armstrong C, editors. Myology 3rd edition. New York: McGraw-Hill; 2004;681–690.
- Finisterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand 2007;116:1–14.